Alphabet's Verily and Novartis eye-care subsidiary Alcon are pulling the plug on the glucose monitoring "smart lens" device the two companies had been attempting to build since 2014, according to a post by Verily chief technical officer Brian Otis on the company's website Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,